This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
S Altman-Hamamdzic , C Groseclose , JX Ma , D Hamamdzic , NS Vrindavanam , LD Middaugh , NP Parratto and FR Sallee (1997). Expression of beta-galactosidase in mouse brain: utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system. Gene Therapy 4: 815–822.
UBR Balasuriya , HW Heidner , NL Davis , HM Wagner , PJ Hullinger , JF Hedges , JC Williams , RE Johnston , WD Wilson , IK Liu and NJ Maclachlan (2002). Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses. Vaccine 20: 1609–1617.
UBR Balasuriya , HW Heidner , JF Hedges , JQ Williams , NL Davis , RE Johnston and NJ Maclachlan (2000). Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles. Journal of Virology 74: 10623–10630.
P Berglund , M Sjoberg , H Garoff , GJ Atkins , BJ Sheahan and P Liljestrom (1993). Semliki Forest virus expression system: production of conditionally infectious recombinant particles. Biotechnology (NY) 11: 916–920.
P Berglund , C Smerdou , MN Flee , I Tubulekas and P Liljestrom (1998). Enhancing immune responses using suicidal DNA vaccines. Nature Biotechnology 16: 562–565.
DI Bernstein , EI Reap , K Katen , A Watson , K Smith , P Norberg , RA Olmsted , A Hoeper , J Morris , S Negri , MF Maughan and JD Chulay (2010). Randomized, double-blind, phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers. Vaccine 28: 484–493.
B Bosworth , MM Erdman , DL Stine , I Harris , C Irwin , M Jens , A Loynachan , K Kamrud and DL Harris (2010). Replicon particle vaccine protects swine against influenza. Comparative Immunology, Microbiology, and Infectious Diseases 33: e99–e103.
A Botner , B Strandbygaard , KJ Sorensen , P Have , KG Madsen , ES Madsen and S Alexandersen (1997). Appearance of acute PRRS-like symptoms in sow herds after vaccination with a modified live PRRS vaccine. Veterinary Record 141: 497–499.
DS Burke and HH Ramsburg (1977). Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine. Journal of Infectious Diseases 136: 354–359.
TD Carrol , SR Matzinger , M Barro , L Fritts , MB McChesney , CJ Miller and RE Johnston (2011). Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone in rhesus macaques. Vaccine 29: 931–940.
JR Ciacci-Zanella , AL Vincent , JR Prickett , SM Zimmerman and JJ Zimmerman (2010). Detection of anti-influenza A nucleoprotein antibodies in pigs using a commercial influenza epitope-blocking enzyme-linked immunosorbent assay developed for avian species. Journal of Veterinary Diagnostic Investigation 22: 3–9.
S Dea , CA Gagnon , H Mardassi , B Pirzadeh and D Rogan (2000). Current knowledge on the structural proteins of porcine reproductive and respiratory syndrome (PRRS) virus: comparison of the North American and European isolates. Archives of Virology 145: 659–688.
GN Defang , D Khetawat , CC Broder and GV Quinnan Jr (2011). Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression system. Vaccine 29: 212–220.
MM Erdman , KI Kamrud , DL Harris and J Smith (2010). Alphavirus eplicon particle vaccines developed for use in humans induce high levels of antibodies to influenza virus hemagglutinin in swine: proof of concept. Vaccine 28: 594–596.
JP Gardner , I Frolov , S Perri , Y Ji , ML MacKichan , Megede J Zur , M Chen , BA Belli , DA Driver , S Sherrill , CD Greer , GR Olten , SW Barnett , MA Liu , TW Dubensky and JM Polo (2000). Infection of human dendritic cells by a Sindbis viral replicon vector is determined by a single amino acid substitution in the E2 glycoprotein. Journal of Virology 74: 11849–11857.
U Geigenmuller-Gnirke , B Weiss , R Wright and S Schlesinger (1991). Complementation between Sindbis viral RNAs produces infectious particles with a bipartite genome. Proceedings of the National Academy of Sciences of the United States of America 88: 3253–3257.
JW Hooper , AM Ferro , JW Golden , P Sivera , JM Dudek , KD Alterson , M Custer , B Rivers , J Morris , G Owens , JF Smith and KI Kamrud (2009). Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates. Vaccine 28: 494–511.
B Hubby , T Talarico , M Maughan , EA Reap , P Berglund , KI Kamrud , L Copp , W Lewis , C Cecil , P Norberg , J Wagner , A Watson , S Negri , BK Burnett , A Graham , JF Smith and JD Chulay (2007). Development and preclinical evaluation of an alphavirus replicon vaccine for influenza. Vaccine 25: 8180–8189.
W Jiang , P Jiang , Y Li , J Tang , X Wang and S Ma (2006a). Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated responses in mice. Veterinary Immunology and Immunopathology 113: 169–180.
Y Jiang , L Fang , S Xiao , H Zhang , Y Pan , R Luo , B Li and H Chen (2006b). Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus. Vaccine 25: 547–560.
Y Jiang , S Xiao , L Fang , X Yu , Y Song , C Niu and H Chen (2006c). DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity. Vaccine 24: 2869–2879.
LJ Johnston , GM Halliday and NJ King (2000). Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus. Journal of Investigative Dermatology 114: 560–568.
J Jose , JE Snyder and RJ Kuhn (2009). A structural and functional perspective of alphavirus replication and assembly. Future Microbiology 4: 837–856.
KI Kamrud , K Alterson , M Custer , J Dudek , C Goodman , G Owens and JF Smith (2010a). Development and characterization of promotorless helper RNAs for the production of alphavirus replicon particles. Journal of General Virology 91: 1723–1727.
KI Kamrud , KD Alterson , C Andrews , LO Copp , WC Lewis , B Hubby , D Patel , JO Rayner , T Talarico and JF Smith (2008). Analysis of Venezuelan equine encephalitis replicon particles packaged in different coats. PLoS ONE 3: 1–8.
KI Kamrud , VM Coffield , G Owens , C Goodman , K Alterson , M Custer , W Lewis , S Timberlake , EK Wansley and P Berglund (2010b). In vitro and in vivo characterization of microRNA-targeted alphavirus replicon and helper RNAs. Journal of Virology 84: 7713–7725.
KI Kamrud , M Custer , JM Dudek , G Owens , KD Alterson , JS Lee , JL Groebner and JF Smith (2007). Alphavirus replicon approach to promoterless analysis of IRES elements. Virology 360: 376–387.
RM Kinney , BJB Johnson , JB Welch , KR Tsuchiya and DW Trent (1988). The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83. Virology 170: 19–30.
A Kohno , N Emi , M Kasai , M Tanimoto and H Saito (1998). Semliki Forest virus-based DNA expression vector: transient protein production followed by cell death. Gene Therapy 5: 415–418.
J Kowalski , K Adkins , S Gangolli , J Ren , H Arendt , J DeStefano , J Obregon , D Tummolo , R Natuk , T Brown , C Parks , S Udem and D Long (2007). Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D. Vaccine 25: 2296–2305.
JS Lee , JL Groebner , AG Hadjipanayis , DL Negley , AL Schmaljohn , SL Welkos , LA Smith and JF Smith (2006). Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice. Vaccine 24: 6886–6892.
JS Lee , AG Hadjipanayis and SL Welkos (2003). Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge. Infection and Immunity 71: 1491–1496.
R Levinson , JH Strauss and EG Strauss (1990). Determination of the complete nucleotide sequence of the genomic RNA of the O'nyong-nyong virus and its use in the construction of phylogenetic trees. Virology 175: 110–123.
N Li , JJ Zhao , HP Zhao , Y Sun , QH Zhu , GZ Tong and HJ Qiu (2007). Protection of pigs from lethal challenge by a DNA vaccine based on an alphavirus replicon expressing the E2 glycoprotein of classical swine fever virus. Journal of Virological Methods 144: 73–78.
P Liljestrom and H Garoff (1991). A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (NY) 9: 1356–1361.
K Ljungberg , AC Whitmore , ME Fluet , TP Moran , RS Shabman , ML Collier , AA Kraus , JM Thompson , DC Montefiori , C Beard and RE Johnston (2007). Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine. Journal of Virology 81: 13412–13423.
GH MacDonald and RE Johnston (2000). Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis. Journal of Virology 74: 914–922.
KG Madsen , CM Hansen , ES Madsen , B Strandbygaard , A Botner and KJ Sorensen (1998). Sequence analysis of porcine reproductive and respiratory syndrome virus of the American type collected from Danish swine herds. Archives in Virology 143: 1683–1700.
ENT Meeusen , J Walker , A Peters , PP Pastoret and G Jungersen (2007). Current status of veterinary vaccines. Clinical Microbiology Reviews 20: 489–510.
JM Minke , JC Audonnet and L Fischer (2004). Equine viral vaccines: the past, present and future. Veterinary Research 35: 425–443.
MM Morris-Downes , KV Phenix , J Smyth , BJ Sheahan , S Lilegvist , DA Mooney , P Liljestrom , D Todd and GJ Atkins (2001). Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems. Vaccine 19: 1978–1988.
EJ Neumann , J Kleibenstein , C Johnson , JW Mabry , EJ Bush , AH Seitzinger , AL Green and JJ Zimmerman (2005). Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. Journal of the American Veterinary Medical Association 227: 385–392.
KP Nishimoto , AK Laust , K Wang , KI Kamrud , B Hubby , JF Smith and EL Nelson (2007). Restricted and selective tropism of a Venezuelan equine encephalitis virus-derived replicon vector for human dendritic cells. Viral Immunology 20: 88–104.
PR Pittman , RS Makuch , JA Mangiafico , TL Cannon , PH Gibbs and CJ Peters (1996). Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine. Vaccine 14: 337–343.
JM Polo , BA Belli , DA Driver , I Frolov , S Sherrill , MJ Hariharan , K Townsend , S Perri , SJ Mento , DJ Jolly , SMW Chang , S Schlesinger and TW Dubensky Jr (1999). Stable alphavirus packaging cell lines for Sindbis virus- and Semliki Forest virus-derived vectors. Proceedings of the National Academy of Sciences of the United States of America 96: 4598–4603.
P Pushko , J Geisbert , M Parker , P Jahrling and J Smith (2001). Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses. Journal of Virology 75: 11677–11685.
P Pushko , M Parker , GV Ludwig , NL Davis , RE Johnston and JF Smith (1997). Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology 239: 389–401.
JO Rayner , SA Dryga and KI Kamrud (2002). Alphavirus vectors and vaccination. Reviews in Medical Virology 12: 279–296.
EA Reap , SA Dryga , J Morris , B Rivers , PK Norberg , RA Olmsted and JD Chulay (2007a). Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins. Clinical and Vaccine Immunology 14: 748–755.
EA Reap , J Morris , SA Dryga , M Maughan , T Talarico , RE Esch , S Negri , B Burnett , A Graham , RA Olmsted and JD Chulay (2007b). Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus. Vaccine 25: 7441–7449.
S Saxena , SS Dahiya , AA Sonwane , CL Patel , M Saini , A Rai and PK Gupta (2008). A Sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge. Vaccine 26: 6592–6601.
S Schultz-Cherry , JK Dybing , NL Davis , C Williamson , DL Suarez , R Johnston and ML Perdue (2000). Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal Infection with Hong Kong-origin H5N1 viruses. Virology 278: 55–59.
SQ Sun , T Liu , HC Guo , SH Yin , YJ Shang , X Feng , ZX Liu and QG Xie (2007). Protective immune responses in guinea pigs and swine induced by a suicidal DNA vaccine of the capsid gene of swine vesicular disease virus. Journal of General Virology 88: 842–848.
MJ Sylte , B Hubby and DL Suarez (2007). Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection. Vaccine 25: 3769–3772.
K Takkinen (1986). Complete nucleotide sequence of the nonstructural protein genes of Semliki Forest virus. Nucleic Acids Research 14: 5667–5682.
AR Thorner , AAC Lemckert , J Goudsmit , DM Lynch , BA Ewald , M Denholtz , MJE Havenga and DH Barouch (2006). Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity. Journal of Virology 80: 12009–12016.
A Uttenthal , S Parida , TB Rasmussen , DJ Paton , B Haas and WG Dundon (2010). Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza. Expert Reviews of Vaccines 9: 73–87.
E Volkova , R Gorchakov and I Frolov (2006). The efficient packaging of Venezuelan equine encephalitis virus-specific RNAs into viral particles is determined by nsp1–3 synthesis. Virology 344: 315–327.
X Yu , S Xiao , L Fang , Y Jiang and H Chen (2006). Enhanced immunogenicity to foot-and-mouth disease virus in mice following vaccination with alphaviral replicon-based DNA vaccine expressing the capsid precursor polypeptide (P1). Virus Genes 33: 337–344.
HP Zhao , JF Sun , N Li , Y Sun , ZH Xia , Y Wang , D Cheng , F Qi , ML Jin and HJ Qiu (2009b). Assessment of the cell-mediated immunity induced by alphavirus replicon-vectored DNA vaccines against classical swine fever in a mouse model. Veterinary Immunology and Immunopathology 129: 57–65.